These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 6286107

  • 21. Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP, Mountjoy KG.
    Cancer Res; 1983 Jun; 43(6):2588-91. PubMed ID: 6850579
    [Abstract] [Full Text] [Related]

  • 22. Prolactin receptors in N-nitroso-N-methylurea-induced rat mammary tumors: relationship to tumor age and down-regulation in short-term explant culture.
    Gandilhon P, Melançon R, Gandilhon F, Djiane J, Kelly PA.
    Anticancer Res; 1983 Jun; 3(3):203-6. PubMed ID: 6307115
    [Abstract] [Full Text] [Related]

  • 23. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM, Milholland RJ, Rosen F, Kim U.
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [Abstract] [Full Text] [Related]

  • 24. Hormone dependency of rat mammary carcinoma--a comparison of two assay systems.
    Sarkar S, Seshadri R, Shah PN, Kothari LS, Ghosh SN.
    Neoplasma; 1979 Mar; 26(4):477-82. PubMed ID: 118387
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Regression of rat mammary tumors associated with suppressed growth hormone.
    Phares CK.
    Anticancer Res; 1986 Feb; 6(4):845-8. PubMed ID: 3019224
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM, Christov K.
    Anticancer Res; 2003 Feb; 23(4):3207-13. PubMed ID: 12931682
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T, Yoshida Y, Kitamura M, Kosaki G.
    Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
    Gandilhon P, Melancon R, Djiane J, Kelly PA.
    J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
    [Abstract] [Full Text] [Related]

  • 36. Role of insulin-like growth factor-related peptides in the estradiol-, prolactin-, and progesterone-stimulated growth of N-nitrosomethylurea-induced rat mammary tumors in soft agar.
    Manni A, Wright C, Badger B, Lynch J, Demers L.
    Cancer Res; 1990 Nov 15; 50(22):7179-83. PubMed ID: 2224853
    [Abstract] [Full Text] [Related]

  • 37. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ, Kledzik GS, Meites J.
    Cancer Res; 1976 Feb 15; 36(2 Pt 1):319-24. PubMed ID: 816459
    [Abstract] [Full Text] [Related]

  • 38. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H, Fukuhara T, Yamashi S, Yoshida A, Fukunishi R, Tsuji M, Matsumoto K.
    Cancer Res; 1983 May 15; 43(5):2311-6. PubMed ID: 6403234
    [Abstract] [Full Text] [Related]

  • 39. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM, Bambara RA, Zain S, Hilf R.
    Cancer Res; 1989 Mar 01; 49(5):1165-70. PubMed ID: 2492902
    [Abstract] [Full Text] [Related]

  • 40. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Waseda N, Kato Y, Matsushita N, Imura H.
    Endocrinol Jpn; 1983 Aug 01; 30(4):529-35. PubMed ID: 6323151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.